One luckless wight contrived to upset the gravy; and then gravy had to be got up de novo
, with due care and formality, Aunt Chloe watching and stirring with dogged precision, answering shortly, to all suggestions of haste, that she "warn't a going to have raw gravy on the table, to help nobody's catchings.
But if I had not taken things for granted, if I had examined everything with care which I should have shown had we approached the case DE NOVO
and had no cut-and-dried story to warp my mind, should I not then have found something more definite to go upon.
Food and Drug Administration regarding its 510(k) submission and will now proceed with a de novo
Food and Drug Administration (FDA) recently released a revised guidance document addressing the de novo
premarket review pathway for medical devices.
Editor Schneider presents this bioorganic synthesis volume focusing on de novo
LAS VEGAS -- A prediction model of seven combined risk factors provides a validated, individualized way to determine a patient's risk for developing de novo
stress urinary incontinence following pelvic prolapse surgery, in a novel study.
SUNNYVALE, California, May 12, 2011 /PRNewswire/ -- De Novo
Software(TM), a leading provider of flow and image cytometry data analysis solutions, and Molecular Devices, a provider of premier bioresearch and drug discovery systems, announced today a licensing agreement enabling Molecular Devices to distribute De Novo
Software's flagship product, FCS Express 4 Software.
One of the existing competitors entered the market de novo
in February 2005 and another commercial banking organization recently received approval to open a de novo
branch in the market.
may sound like a complex legal term, but it is simply a Latin term meaning "anew.
Robinette wanted a de novo
(to start anew) review on the grounds the tax liability was at issue.
SB 548 (Burton) would allow the FTB to bring a trial de novo
proceeding in superior court after the Board of Equalization had ruled in the taxpayer's favor.
Therefore, both programs' objectives include a balanced portfolio of projects developing both de novo
and re-sequencing technologies.